Conversely, once eGFR drops below threshold values, pathophysiological cascades (involving endothelial dysfunction, advanced glycation end products, and local cytokine release) may progressively reduce GPR‐120 [27,28]. Beyond statistical associations, biological plausibility supports a direct role for GPR-120 in renal protection. The gene discussed is FFAR4; the disease is endothelial dysfunction.